Showing results (51-60 of 275) with videos related to
Sort By:
Pageof 28
Breast Cancer Research and Treatment|February 6, 2010
Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cellsMahvash Zakikhani, Marie-José Blouin, Esther Piura, et al.International Journal of Cancer|August 1, 2009
Incident cancer burden attributable to excess body mass index in 30 European countriesAndrew G Renehan, Isabelle Soerjomataram, Margaret Tyson, et al.Plos Medicine|February 22, 2019
COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiologyOlaf M Dekkers, Jan P Vandenbroucke, Myriam Cevallos, et al.European Journal of Cancer (Oxford, England : 1990)|November 22, 2011
Body mass index does not influence post-treatment survival in early stage endometrial cancer: results from the MRC ASTEC trialEmma J Crosbie, Chris Roberts, Wendi Qian, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2016
How to Manage the Obese Patient With CancerAndrew G Renehan, Michelle Harvie, Ramsey I Cutress, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 15, 2014
The use of metformin in patients with prostate cancer and the risk of deathLeah Bensimon, Hui Yin, Samy Suissa, et al.International Journal of Cancer|November 15, 2005
Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, CanadaMarie-Claude Rousseau, Marie-Elise Parent, Michael N Pollak, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 23, 2013
The use of metformin and colorectal cancer incidence in patients with type II diabetes mellitusBrielan Smiechowski, Laurent Azoulay, Hui Yin, et al.Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinaseMahvash Zakikhani, Ryan J O Dowling, Nahum Sonenberg, et al.Cancer Causes & Control : CCC|January 4, 2014
Type 2 diabetes and the risk of mortality among patients with prostate cancerLeah Bensimon, Hui Yin, Samy Suissa, et al.Pageof 28